Drug Safety in the Limelight

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2003, Volume 27, Issue 5

FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.

Related Content:

Regulatory WatchPharmaceutical Technology-05-02-2003
FDA Interactions with Industry Under Scrutiny
A Rocky Road Ahead for FDA and Industry
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing